I received the AST merger proxy email on the 6th January which explained how to vote on-line. The email contained a unique shareholder code which enabled you to log in and vote. I voted in favour of the merger. Like other BTA shareholders I lost a motza on their mishandling of the shift to the NASDAQ. It beggars belief that they could fail to capitalise on the $300mUS grant from the US Dept of Health to trial Inavir and end up with nothing. The merger is by far our best option - injecting new blood and promising new range of oral vaccines. Regards, Kangaroo1
